Fantastic announcement.
Significant potential in UAE alone combining initial pediatric heart operations + repeat operations from babies which have previously received inferior patches + adult heart operations (non CHD related.)
Will also have a positive effect for when VascuCel is released there which should be in the near future.
And will hopefully act as an incentive for other MENA countries to approve and start ordering CardioCel soon.
Wayne Paterson and Admedus continue to do brilliantly.
Ann: CardioCel receives market approval in UAE, page-11
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.15 |
Change
-0.250(2.40%) |
Mkt cap ! $214.5M | |||
| Open | High | Low | Value | Volume |
| $10.57 | $10.59 | $9.90 | $181.3K | 17.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 720 | $10.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.35 | 3407 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |